Talk Infusion: How will the Inflation Reduction Act Impact Home Infusion?

Recorded On: 08/31/2022

Join our panel of industry leaders for this forward-looking discussion on the fascinating implications of the broad-reaching Inflation Reduction Act (IRA) on the home and alternate site infusion industry.

Relevant provisions in the IRA include:

  • $2,000/year cap on patient out-of-pocket costs for Medicare Part D drugs, beginning in 2025 
  • Medicare can negotiate the price of prescription drugs with manufacturers, beginning with 10 drugs in 2026, expanding by 15 drugs in 2027 and 2028, and expanding again by 20 drugs in 2029--for a total of 60 drugs by 2029
  • Pharmaceutical companies will be required to issue an “inflation rebate” for Medicare drugs whose prices they set higher than the rate of inflation. A similar provision for drugs covered under commercial insurance failed.

Panelists will include:

  • Connie Sullivan, NHIA President and CEO
  • Logan Davis, Vice President of Trade, Vital Care Inc
  • Jayson Slotnick, Partner, Health Policy Strategies
  • Jennifer Snow, Vice President of Market Economics, AmerisourceBergen

We will also provide a brief update on the status and timeline for the Preserving Patient Access to Home Infusion Act.

Talk Infusion 2022 Webinar Series Sponsored by McKesson.

Connie Sullivan

President & CEO

National Home Infusion Association

Connie Sullivan, BSPharm, is the President and CEO of NHIA. Prior to joining the NHIA staff, Sullivan was a practicing home infusion pharmacist and National Infusion Director for HCR ManorCare for 15 years. She is the Vice Chair of USP’s Sterile Compounding Expert Committee and USP’s Parenteral Nutrition Safety Expert Panel.

No Disclosures to Report

Logan Davis

VP of Trade

Vital Care Infusion Services

Logan is a pharmacist and Director of Trade and Business Development with Vital Care Infusion Services, a national infusion pharmacy franchise organization based in Meridian, Mississippi.  Vital Care’s growing network of franchisees provide infusion services in multiple sites of care including home infusion, infusion suites, and infusion clinics.  In his role he leads a team responsible for trade contracting and business development. He is a co-owner of multiple Vital Care franchises, and serves on the Board of Directors for the National Home Infusion Association.

No Disclosures to Report

Jayson Slotnick

Partner

Health Policy Strategies

No Disclosures to Report

Jennifer Snow

VP of Market Economics

AmerisourceBergen

No Disclosures to Report

Key:

Complete
Failed
Available
Locked
LIVE WEBINAR | How will the Inflation Reduction Act Impact Home Infusion?
08/31/2022 at 1:00 PM (EDT)   |  60 minutes
08/31/2022 at 1:00 PM (EDT)   |  60 minutes Join our panel of industry leaders for this forward-looking discussion on the fascinating implications of the broad-reaching Inflation Reduction Act (IRA) on the home and alternate site infusion industry.
Post Webinar Survey
3 Questions
3 Questions Talk Infusion: How will the Inflation Reducation Act Impact Home Infusion NHIA Webinar 2022 - Non CE